Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Its available through US providers like AgelessRx, where its compounded by a licensed pharmacy and dosed under provider supervision
It also shares links with autoimmune diseases, neurological disorders, and erectile dysfunction
Do not shake vigorously, as agitation can denature the longer protein chains
doses selected for the global Phase 3 pivotal program of GH001 in TRD GH001-HV-109 US IND-opening study enrolment completed Cash, cash equivalents and marketable securities of $267.3 million as of March 31, 2026 Net cash proceeds of an additional $111.2 million from underwritten offering received in April 2026 DUBLIN, May 14, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today reported financial results for the quarter ended March 31, 2026, and provided a business update
US$ 22.77
US$ 25.90
US$ 26.86
US$ 27.77
